Testosterone and coronary heart disease: is there a link?
|
|
- Adam Taylor
- 8 years ago
- Views:
Transcription
1 Q) Med 1997; 90: Commentary QJM Testosterone and coronary heart disease: is there a link? K.M. ENGLISH, R. STEEDS, T.H. JONES 1 and K.S. CHANNER From the Departments of Cardiology and ^ Endocrinology, Royal Hallamshire Hospital, Sheffield, UK Introduction Despite a ten-fold difference in total coronary artery disease (CAD) mortality in 50 countries, the maleto-female ratio remains remarkably constant at around two. 1 How is this excess risk in men explained? There is a higher prevalence of hypertension, smoking and hyperlipidaemia in men, and those males affected by these risk factors have higher mortality than similarly-affected women. However, when the risks associated with high systolic blood pressure, cigarette smoking, raised cholesterol, raised fasting plasma glucose, and obesity are controlled for by means of a multiple logistic analysis, a significant sex difference still remains. 2 In women, early menopause is associated with an increased risk of cardiovascular disease, 3 and myocardial infarction is more common following bilateral oopherectomy. 4 By comparison, exogenous oestrogen use is protective against CAD in postmenopausal women, 5 and high levels of endogenous oestrogen may explain the extremely low prevalence of CAD in pre-menopausal women. Women with the polycystic ovary syndrome have a higher than normal level of testosterone which is associated with obesity, insulin resistance, low levels of high-density lipoprotein cholesterol (HDLC), 6 and an increased risk of myocardial infarction. 7 It seems therefore, in women, that physiological levels of endogenous oestrogen are protective, while abnormally high levels of testosterone are detrimental. By contrast, in men, high levels of oestrogen and oestrone are associated with increased risks of myocardial infarction, angina and CAD at angiography. 8 Giving oestrogens to men with prostatic carcinoma is associated with increased mortality from CAD, 9 and oestrogens given to male survivors of myocardial infarction lead to an increased re-infarction rate. 10 Not only do high levels of oestrogen appear detrimental in men, but there is evidence to suggest that low levels of testosterone are also associated with an increased risk of CAD. It may be the different balance of androgens and oestrogens in the two sexes which is important in determining the sex difference in mortality from CAD. Testosterone and atherogenesis The premature development and progression of atheroma is dependent upon the interaction of a number of risk factors which have been identified in recent years. These risk factors (hypertension, dyslipidaemia, diabetes, high fibrinogen, obesity and smoking), tend to cluster in individuals and in families. Although there are substantial data regarding the risks associated with these conditions, common causative links and the mechanisms by which they interact with each other are poorly understood. Abnormalities in the balance of sex hormones may be implicated. Testosterone and lipids Different lipoproteins are of varying importance in the development of atheroma. High levels of lowdensity lipoprotein cholesterol (LDLC) and lipoprotein a are strongly associated with the development of CAD, whereas high levels of HDLC are protective. Men have an atherogenic profile, with lower levels of HDLC and higher levels of LDLC compared with pre-menopausal women or pre-pubescent boys. Address correspondence to Dr K.M. English, Department of Cardiology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF Oxford University Press 1997
2 788 KM. English et al. These differences between men and women may reflect an interaction with the balance of sex hormones, and since these are derivatives of cholesterol, a close link may be expected. Studies in normal men have consistently shown a positive correlation between total or free testosterone level and HDLC, and a negative correlation with LDLC and triglycerides. 11 " 15 Serum lipoprotein a levels are decreased in normal men by the administration of exogenous testosterone. 16 ' 17 Thus, men with hypotestosteronaemia have a pro-atherogenic lipid profile. However, intervention trials have produced conflicting results. Chemically-induced hypogonadism by gonadotrophin-releasing-hormone analogues induces a rise in HDLC, which is corrected with intramuscular testosterone enanthate therapy. 18 " 20 Results of these intervention studies should not to be used to draw conclusions about the lipid abnormalities seen in naturally occurring hypogonadism. Testosterone and hypertension Both systolic and diastolic hypertension are established risk factors for CAD. The direct influence of sex hormones on blood pressure control has not been studied as a primary objective. A number of investigators have looked at the relationship between blood pressure and testosterone as part of casecontrol studies of many CAD risk factors. They have found a consistent relationship between hypotestosteronaemia and raised systolic and diastolic blood pressure. 11 Low mean levels of testosterone have been found in populations of hypertensive men. 21 Moreover, a high oestradiohtestosterone ratio is associated with a high renin-sodium profile in hypertensive men, 22 suggesting a possible aetiological link. Testosterone and insulin resistance/obesity Hyperinsulinaemia is a risk factor for coronary artery disease. 23 Many studies have investigated the relationship between androgens and insulin level in women, but relatively few have studied the relationship in men. There is an association in men between low free and total testosterone and hyperinsulinaemia; this relationship being converse to that seen in women. 11 ' 24 Similarly, total testosterone has been shown to be lower in non-insulin-dependent diabetic men who have higher plasma insulin levels than in normoglycaemic men. 12 In centrally-obese middleaged men, testosterone replacement reduces hyperinsulinaemia. 25 Obesity and increased waist:hip ratio are both predictors of hyperinsulinaemia. Free and total testosterone are decreased in proportion to the degree of obesity, 26 and a significant correlation has been found between decreased testosterone blood level and increased waistrhip ratio. 11 ' 24 ' 42 This relationship may be explained by the fact that the oestrogen:testosterone ratio is determined, at least in part, by the peripheral conversion of androstenedione to oestrone by aromatase activity in adipose tissue and muscle. Thus, men with android obesity have lower testosterone levels, secondary to increased conversion of androgens to oestrogens in peripheral fat, and have a higher risk of CAD. Testosterone and smoking Estradiol levels are increased in otherwise healthy, young male smokers. 29 A recent study has demonstrated significant reductions in total testosterone levels in rats exposed to cigarette smoke for 60 days. This was associated with degeneration of Leydig cells on histological examination of the testis. 28 However, human studies have shown conflicting results, with some authors reporting low serum testosterone levels in smokers, 29 while others have found high levels. 30 ' 31 Testosterone and fibrinogen Fibrinogen is an independent risk factor for myocardial infarction and atheroma formation. 32 ' 33 Low levels of serum testosterone are associated with high fibrinogen levels, 34 ' 35 ' 37 and administration of exogenous testosterone causes fibrinogen levels to fall. 37 Low levels of testosterone may therefore predispose to accelerated atheroma formation through its effect on fibrinogen. Testosterone and age Increased age is one of the strongest predictors for coronary artery disease. The Telecom Study of 1400 males aged between 20 and 60 years demonstrated a significant stepwise decrease in testosterone concentration with each decade. This relationship was maintained after the exclusion of patients with chronic disease and statistical correction for body mass index, alcohol consumption and subscapular skin-fold thickness. 38 Testosterone and atheroma at coronary angiography The summary of the evidence above shows clearly that a low level of serum testosterone is associated with all the common risk factors for CAD. If the association were of pathogenic significance, it should be reflected in a correlation between testosterone concentration and findings at coronary angiography. A significant negative correlation between testosterone level and the presence of CAD has been found in two studies using coronary angiography to detect
3 Testosterone and CHD 789 evidence of atheroma. 39 ' 40 Furthermore, Philips et al. found a significant negative correlation between total or free testosterone and the degree of CAD (as defined by the mean % arterial occlusion) in 55 men undergoing coronary angiography. 41 Testosterone and acute coronary thrombosis Ninety percent of cases of myocardial infarction follow an acute thrombotic occlusion of an already damaged coronary artery. As already discussed, a low level of testosterone is associated with coronary atheroma. Is low testosterone also implicated in acute thrombotic episodes? Testosterone and haemostasis/fibrinolysis A number of studies have investigated the role of testosterone in the haemostatic/fibrinolytic pathways, with uniform results. 34 " 36 Testosterone has been positively correlated with tissue plasminogen activator (the major stimulator of fibrinolysis) and negatively with the procoaguable factors, plasminogen activator inhibitor, fibrinogen, alpha-2 antiplasmin and factor Vile. These results remain significant after control for other variables. Furthermore, exogenous testosterone administration causes a fall in plasma fibrinogen and plasminogen activator inhibitor. 37 Hypotestosteronaemia is therefore implicated in a pro-thrombotic tendency, and theoretically would be associated with an increased risk of acute myocardial infarction and thrombotic stroke, whereas a physiological level of testosterone should decrease thrombotic risk by reducing fibrinogen and increasing fibrinolytic activity. Testosterone and myocardial infarction Numerous studies have attempted to clarify the relationship between sex hormones and acute myocardial infarction. Many of these primarily studied oestrogen, oestradiol and oestrone, with testosterone being a secondary measurement. The period immediately prior to myocardial infarction is inevitably difficult to study, but a number of centres have demonstrated significantly low levels of testosterone immediately following myocardial infarction. 42 ' 43 This is, however, not a consistent finding, with the majority of studies showing no significant differences, 44 " 47 Profiling of testosterone has demonstrated that the low levels seen post infarct may be due to an immediate fall in testosterone which subsequently returns to normal. 48 This is mirrored by similar falls following surgery and trauma, suggesting it may be an acute response. 49 A recent study in Denmark has examined the relationship between low testosterone and acute ischaemic stroke in 144 men. The authors found that total testosterone level was inversely associated with stroke severity, infarct size and six-month mortality. 50 Again, these results may be due to an acute fall in testosterone levels following acute stroke. These studies do not show a causative link between a low level of testosterone and acute thrombotic events, but raise enough questions to warrant further studies. Testosterone and coronary artery disease mortality Work to date provides circumstantial evidence of a link between low testosterone levels, atherogenesis and acute arterial thrombosis. However, studies examining the association between low testosterone and CAD mortality have been inconclusive. A study of 1000 men aged between 40 and 79 years looked at the development of cardiovascular disease (heart attack, heart failure or stroke) over a 12-year period, and correlated this with total testosterone level taken at the beginning of the trial. The investigators found no significant association between total testosterone at baseline and the prevalence or development of cardiovascular disease. 51 A further study of the stored sera of 163 men who died from a definite myocardial infarct or from coronary heart disease compared with 163 matched controls found no significant difference between free or total testosterone in cases or controls. 52 The Caerphilly Heart Study again did not find testosterone level to be a primary risk factor for CAD mortality. 53 All these studies have limitations: particularly, Barrett-Connor et a/. 51 did not examine free testosterone levels, and the population in the Caerphilly Heart Study 53 was relatively young (aged years) and followed for only 5 years. Stronger evidence might have been produced had the study been extended for a longer period. A further limitation in the study of the relationship between testosterone and CAD is that the measurement of testosterone has only been possible since the 1960s, and is still being developed. It can be subject to methodological problems, which arise from the fact that 98% of testosterone is bound to sex-hormone-binding globulin, and to a lesser extent, albumin. The assays for free testosterone are improving, but their sensitivity is not good enough to define borderline hypogonadism clearly. The measurement of testosterone is further complicated by its diurnal and circannual variation and wide intra-individual variability. Conclusions The protective value of sex hormones appears to be sex-specific, and the ratio of oestrogen to testosterone may be important. Oestrogens appear protective in women but detrimental in men, whereas it appears
4 790 KM. English eta\. that testosterone is protective in men, yet deleterious in women. A normal physiological level of testosterone in men may protect against the development of hyperlipidaemia, hyperinsulinism, hypertension, thrombophilic tendency, obesity and increased waist:hip ratio, all of which predispose to the development of CAD. Low or low normal testosterone may also be implicated in the pathogenesis of acute myocardial infarction and acute stroke. The decline of testosterone with age may partly explain the greater risk of CAD with advancing years. Moreover, there may be a population of younger men with relative hypogonadism who are at increased risk of premature CAD, complaining only of fatigue and depression, in whom the true diagnosis is unsuspected and undiagnosed. Trials examining the association between CAD mortality and morbidity and sex hormone levels in men need to be large and over long time periods to identify trends associated with small differences in sex hormones. The importance of testosterone in the pathogenesis of CAD may be in part due its effect in the short or medium term on lipids or coagulation factors. Clearly, studies to determine the significance of these different effects in different time scales need to be sophisticated in design. Now is the time to undertake the large prospective trials required to establish a cause and effect relationship between low testosterone levels and CAD. References 1. British Heart Foundation Statistics Database. BHF, 1996: Wingard DL, Suarez L, Barrett-Connor E. The sex differential in mortality from all causes and ischaemic heart disease. Am J Epidemiol 1983; 117(2): Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and the risk of cardiovascular disease. The Framingham Study. Ann Intern Med 1976; 85: Colditz CA, Willett MD, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N EnglJMed 1987; 316(18): Stampfer MJ, Colditz CA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. N EnglJ Med 1991; 325: Conway CS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 1992; 37: La Vecchia C, Decarli A, Franceschi S, Gentile A, Negri E, Parazzini F. Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age. Am) Obstet Gynaecol 1987; 157: Luria MH, Johnson MW, Pego R, Seuc CA, Manubens SJ, Wieland MR. Relationship between sex hormones, myocardial infarction and occlusive coronary disease. Ann Intern Med 1982; 142: Gardner AM, Setakis N. Carcinoma of the prostate. Increased mortality and cardiovascular complications associated with oestrogen therapy as compared with orchidectomy. Bristol Medico-Chirurgical J 1983; 98: Coronary Drug Project Research Group(1970). Initial findings leading to a modification of its research protocol. 1970; 214: Simon D, Charles MA, Nahoul K, Orssaud G, Kremski J, Hully V, et al. Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. J Clin Endocrinol Metab 1997; 82(2): Barrett-Connor E. Lower endogenous androgen levels and dyslipidaemia in men with NIDDM. Ann Intern Med 1992; 117: Mendoza S, Osuna A, Zerpa A. Hypertriglyceridaemia and hypoalphalipoproteinaemia in oligospermic and azoospermic young men; Relationships of endogenous testosterone to triglyceride and HDL cholesterol metabolism. Metabolism 1981; 30(5): Dai WS, Gutai JP, Kuller LH. Relation Between plasma HDL cholesterol and sex hormone concentrations in men. Am J Cardiol 1984; 53: Heller R, Wheeler MJ, Micallef J. Relationship of HDL cholesterol with total and free testosterone and SHBG. Acta Endocrinologica 1983; 194: Berglund L, Carlstrom K, Stege R, Gottlieb C, Eriksson M, Angelin B, era/. Hormonal regulation of serum lipoprotein a levels: Effects of parenteral administration of estrogen or testosterone in males. J Clin Endocrinol Metab 1996; 81(7): Zmuda JM, Thompson PD, Dickenson R, Bausserman LL. Testosterone decreases lipoprotein a in men. Am J Cardiol 1996; 77: Bagatell CJ, Knopp RH, Vale WW, Rivier JE, Bremner WJ. Physiological testosterone levels in normal men suppress HDL cholesterol levels. Ann Intern Mec/1992; 116(12.1): Sorva R, Kuusi T, Taskinen MR, Perheentupa J, Nikkila EA. Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. Atherosclerosis 1988; 69: Goldberg RB, Rabin D, Alexander AN, Doelle GC, Getz GS. Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apoproteins A1 and B. J Clin Endoc and Metab 1985; 60(1): Phillips GB, Jing TY, Resnick LM, Barbagallo M, Laragh JH, Sealey JE. Sex hormones and haemostatic risk factors for coronary heart disease in men with hypertension. J Hypertens 1993; 11: Phillips GB, Jing TY, Laragh JH, Sealey JE. Serum sex hormone levels and renin-sodium profile in men with hypertension. Am J Hypertens 1995; 8(6): Ducimetiere p, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle aged population. Diabetologia 1980; 19: Haffner SM, Karhapaa P, Mykkanen L, Laakso M. Insulin resistance, body fat distribution and sex hormones in men. Diabetes 1994; 43: Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, ef al. The effects of testosterone on body composition
5 Testosterone and CHD 791 and metabolism in middle aged men. IntJ Obes Relat Metab Disord 1992; 16: Zumoff B, Strain GS, Miller LK, Rosner W, Senie R, Seres S, Rosenfeld RS. Plasma free and non-sex-hormone-bindingglobulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab 1990; 71: Klaiber EL, Broverman DM, Dalen JE. Serum estradiol levels in male cigarette smokers. AmJ Med 1984; 77: Yardimci S, Atan A, Delibasi T, Sunguroglus K, Cuven MC. Long-term effects of cigarette smoke exposure on plasma testosterone, luteinizing hormone and follicle stimulating hormone levels in male rats. BrJ Urol 1997; 79: Anderson AN, Semczuk M, Tabor A. Prolactin and pituitarygonadal function in cigarette smoking infertile patients. Andrologia 1984; 16: Vermeulen A, Kaufman JM, Ciagulli VA. Influence of some biological indexes on sex hormone binding globulin and androgen levels in ageing or obese males. J Clin Endocrinol /Vfefab1996;81(5): Field AE, Colditz CA, Willett WC, Longcope C, McKinley JB. The relation of smoking, age relative weight and dietary intake to serum adrenal steroids, sex hormones, and sex hormone binding globulin in middle-aged men. J Clin Endocrinol Metab 1994; 79(5): Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: Meade TW. Fibrinogen in ischaemic heart disease. Eur Heart J 1995; 16(supplement A): Glueck CJ, Glueck HI, Stroop D, Spiers J, Hamer T, Tracy T. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidaemic men. J Lab Clin Med 1993; 122: Caron P, Benet A, Camare R, LouvetJP. Plasminogen activator inhibitor in plasma is related to testosterone in men. Metabolism 1988; 38(10):! Bonithon-Kopp C, Scarabin PY, Bara L. Relationship between sex hormones and haemostatic factors in healthy middle-aged men. Atherosclerosis 1988; 71: Anderson RA, Ludlam CA, Wu FC. Haemostatic effects of supraphysiological levels of testosterone in normal men. Thromb Haemostas 1995; 74(2): Simon D, Preziosi P, Barrett-Connor E, Roger M, Sait-Paul M, Nahoul K, Papoz L. The influence of ageing on plasma sex hormones in men. The Telecom Study. Am J Epidemiol 1992; 135(7) Barth JD, Jansen H, Hugenholtz PG, Birkenhager JC. Postheparin lipases, lipids and related hormones in men undergoing arteriography to assess atherosclerosis. Atherosclerosis 1983; 48: Chute CG, Baron JA, Plymate SR, Kiel DP, Pavia AT, Lozner EC, etal. Sex hormones and coronary artery disease. Am J Med 1987; 83: Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronaemia with coronary artery disease in men. Arterioscler Thromb Vase Biol 1994; 14(5): Aksut SV, Aksut G, Karamehmetoglu A, Oram E. The determination of serum estradiol, testosterone and progesterone in acute myocardial infarction. Jpn Heart 71986; 27: Kahl Von PE, Lampe D, Schollberg K, Lachman I, Mai I. Serum estradiol levels in the post acute phase of myocardial infarction. Deutsche Gesundh-Wesen 1979; 34: Heller RF, Jacobs HS, Vermeulen A, Deslypere JP. Androgens, oestrogens and coronary heart disease. Br Med 71981; 282: Franzen J, Fex G. Low serum apolipoprotein A-1 in acute myocardial infarction survivors with normal HDL cholesterol. Atherosclerosis 1986; 59: Small M, Lowe GDO, Beastall GH, Beattie JM, McEachern M, Hutton I, etal. Serum oestradiol and ischaemic heart disease Relationship with myocardial infarction but not coronary atheroma or haemostasis. QJ Med 1985; 57(223) Luria MH, Johnson MW, Pego R, Seuc CA, Manubens SJ, Wieland MR, Wieland RG. Relationship between sex hormones, myocardial infarction, and occlusive coronary disease. Arch Intern Med 1982; 142: Wang C, Chan V, Tse TF, Yeung RT. Effect of acute myocardial infarction on pituitary-testicular function. Clin Endocrinol 1978; 9: Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotrophic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985; 60: Jeppeson LL, Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS, Winther K. Decreased testosterone in men with acute ischaemic stroke. Arterioscler Thromb Vase Biol 1996; 16(6) Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective population based study. Circulation. 1988; 78: Cauley JA, Gutai JP, Kuller LH, Dai WS. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am J Carc//o/1987; Yarnell JW, Beswick AD, Sweetnam PM, Riad-Fahmy D. Endogenous sex hormones and ischaemic heart disease in men. The Caerphilly Heart Study. Arterioscler Thromb Vase Biol 1993; 13(4):
Serum testosterone and short-term mortality in men with acute myocardial infarction
ORIGINAL ARTICLE Cardiology Journal 2010, Vol. 17, No. 3, pp. 249 253 Copyright 2010 Via Medica ISSN 1897 5593 Serum testosterone and short-term mortality in men with acute myocardial infarction Constantin
More informationCardiovascular Disease in Men
539 Endogenous Sex Hormones and Cardiovascular Disease in Men A Prospective Population-Based Study Elizabeth Barrett-Connor, MD, and Kay-Tee Khaw, MRCP, MSc Plasma obtained and frozen in 1972-1974 from
More informationThe observations in men of hyperestrogenemia
701 The Association of Hypotestosteronemia With Coronary Artery Disease in Men Gerald B. Phillips, Bruce H. Pinkernell, Tian-Yi Jing Abstract Hyperestrogenemia and hypotestosteronemia have been observed
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME
1 University of Papua New Guinea School of Medicine and Health Sciences Division of Basic Medical Sciences Discipline of Biochemistry and Molecular Biology PBL SEMINAR INSULIN RESISTANCE, POLYCYSTIC OVARIAN
More informationMen Sexual Dysfunction Associated with Obesity and Metabolic Syndrome
Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome By Aly A. Abbassy, MD, FACE Professor of Medicine (Endocrinology) Alexandria University My Talk will include: 1-Types of Men sexual
More informationThe Relationship Between Low Testosterone and Cardiovascular Disease
Testosterone and Cardiovascular Risk in Men Daniel M. Kelly a T. Hugh Jones a, b a Department of Human Metabolism, Medical School, The University of Sheffield, Sheffield, and b Centre for Diabetes and
More informationEffect of cigarette smoking on levels of bioavailable testosterone in healthy men
Clinical Science (2001) 100, 661 665 (Printed in Great Britain) 661 Effect of cigarette smoking on levels of bioavailable testosterone in healthy men Katherine M. ENGLISH*, Peter J. PUGH*, Helen PARRY*,
More informationHôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires
Hôpitaux Universitaires de Genève Lipides, métabolisme des hydrates de carbonne et maladies cardio-vasculaires Prof. J. Philippe Effect of estrogens on glucose metabolism : Fasting Glucose, HbA1c and C-Peptide
More information1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome
More informationTestosterone and Heart Disease
Testosterone and Heart Disease By Pamela W. Smith, M.D., MPH, MS Introduction Two recent trials suggest that testosterone replacement therapy may increase the risk of heart disease and/or stroke. 1, 2
More informationInternational Journal of Pharma and Bio Sciences RELATIONSHIP OF TESTOSTERONE LEVELS IN MALES WITH CORONARY HEART DISEASE
International Journal of Pharma and Bio Sciences RESEARCH ARTICLE BIO CHEMISTRY RELATIONSHIP OF TESTOSTERONE LEVELS IN MALES WITH CORONARY HEART DISEASE MAMTA SETH *1, ASHUMA SACHDEVA 2, PRASANTA SAHAROY
More informationPlasma Testosterone Level in Male Patients with Metabolic Syndrome
Med. J. Cairo Univ., Vol. 77, No. 1, June: 351-357, 2009 www.medicaljournalofcairouniversity.com Plasma Testosterone Level in Male Patients with Metabolic Syndrome NASHWA EL-SARRAF, M.D. and AMR EL-HADIDY,
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationPsoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
More informationEducation. Panel. Triglycerides & HDL-C
Triglycerides & HDL-C Thomas Dayspring, MD, ACP Clinical Assistant Professor of Medicine University of Medicine and Dentistry of New Jersey Attending in Medicine: St Joseph s s Hospital, Paterson, NJ Certified
More informationHEALTH UPDATE. Polycystic Ovary Syndrome (PCOS)
HEALTH UPDATE PO Box 800760 Charlottesville, VA 22908 Gynecology: (434) 924-2773 Polycystic Ovary Syndrome (PCOS) What is it? An endocrine (hormonal) disorder. Because there is such variability in how
More informationThe WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?
AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division
More informationHypogonadism and Testosterone Replacement in Men with HIV
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Hypogonadism and Testosterone Replacement in Men with HIV Stephanie T. Page, MD, PhD Robert B. McMillen Professor in Lipid Research, Associate Professor of
More informationFocus. Andropause: fact or fiction? Introduction. Johan Wilson is an Auckland GP KEY POINTS
1 of 5 Focus Andropause: fact or fiction? Johan Wilson is an Auckland GP Introduction Androgen deficiency in the ageing male, or andropause, is being diagnosed with increased frequency. A growing body
More informationRelation of Serum Testosterone Levels to High Density Lipoprotein Cholesterol and Other Characteristics in Men
37 Relation of Serum Testosterone Levels to High Density Lipoprotein Cholesterol and Other Characteristics in Men David S. Freedman, Thomas R. O'Brien, W. Dana Flanders, Frank DeStefano, and Joseph J.
More informationEUROPEAN JOURNAL EPIDEMIOLOGY
Eur. J. Epidemiol. 0392-2990 March 1993, p. 134-139 EUROPEAN JOURNAL OF EPIDEMIOLOGY Vol. 9, No. 2 HIGH BI~OOD PRESSURE AND THE INCIDENCE OF NON-INSULIN I)EPENDENT DIABETES MELI,ITUS: FINDINGS IN A 11.5
More informationYour Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized
More informationMultiple comorbidities: additive and predictive of cardiovascular risk. Peter M. Nilsson Lund University University Hospital Malmö, Sweden
Multiple comorbidities: additive and predictive of cardiovascular risk Peter M. Nilsson Lund University University Hospital Malmö, Sweden Clinical outcomes: major complications of CVD Heart Attack/ACS
More informationTestosterone Treatment in Older Men
Testosterone Treatment in Older Men J. Bruce Redmon, M.D. Professor Division of Endocrinology Departments of Medicine and Urologic Surgery Disclosure Information I have no financial relationships to disclose.
More informationRole of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
More informationMY TYPE 2 DIABETES NUMBERS
BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationSerum Testosterone Levels and Arterial Blood Pressure in the Elderly
625 Original Article Hypertens Res Vol.28 (2005) No.8 p.625-630 Serum Testosterone Levels and Arterial Blood Pressure in the Elderly Roberto FOGARI, Paola PRETI, Annalisa ZOPPI, Elena FOGARI, Andrea RINALDI,
More informationYour healthcare provider has ordered a Boston Heart Cardiac Risk Assessment
Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).
More informationPOSTMENOPAUSAL HYPERANDROGENEMIA (ANDROID OBESITY, INSULIN RESISTANCE, DIABETES MELLITUS) AND THERAPEUTIC CONSEQUENCES
MENOPAUSE ANDROPAUSE Postmenopausal Hyperandrogenemia 159 POSTMENOPAUSAL HYPERANDROGENEMIA (ANDROID OBESITY, INSULIN RESISTANCE, DIABETES MELLITUS) AND THERAPEUTIC CONSEQUENCES D. FOTH, TH. RÖMER POSTMENOPAUSAL
More informationCalcium. Table 1: Difference between method means in percent
Calcium Measurement of total calcium is widely used for both the diagnosis and the monitoring of a range of conditions related to the bones, heart, nerves, and kidneys. Total calcium measurements include
More informationProtocol: Alcohol consumption and diabetes risk factors: a meta-analysis of interventional studies
Protocol: Alcohol consumption and diabetes risk factors: a meta-analysis of interventional studies Version: 1 Date: Study team: C Mary Schooling, CUNY School of Public Health at Hunter College, 2180 Third
More informationLDL PARTICLE SIZE: DOES IT MATTER? Samia Mora, M.D., M.H.S., Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts.
LDL PARTICLE SIZE: DOES IT MATTER? Samia Mora, M.D., M.H.S., Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts Introduction While both small and large LDL particles may be atherogenic,
More informationFebruary 1, 2014 RESTORING STRENGTH AND VITALITY THROUGH HORMONES FACTS, FANTASIES, POSSIBILITIES, AND PITFALLS
February 1, 2014 RESTORING STRENGTH AND VITALITY THROUGH HORMONES FACTS, FANTASIES, POSSIBILITIES, AND PITFALLS Calvin Hirsch, MD Professor of Clinical Internal Medicine (Geriatrics) UC Davis School of
More informationMetabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
More informationtestosterone_pellet_implantation_for_androgen_deficiency_in_men 10/2015 N/A 11/2016 10/2015 This policy is not effective until December 30, 2015
Corporate Medical Policy Testosterone Pellet Implantation for Androgen Deficiency in File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testosterone_pellet_implantation_for_androgen_deficiency_in_men
More informationAfrican Americans & Cardiovascular Diseases
Statistical Fact Sheet 2013 Update African Americans & Cardiovascular Diseases Cardiovascular Disease (CVD) (ICD/10 codes I00-I99, Q20-Q28) (ICD/9 codes 390-459, 745-747) Among non-hispanic blacks age
More informationGARY S. DONOVITZ, M.D., F.A.C.O.G.
Sub-Cutaneous Hormone Pellet Therapy- The Comprehensive Treatment to Optimize and Balance Hormones Using the BioTE Method GARY S. DONOVITZ, M.D., F.A.C.O.G. The BioTE method of hormone replacement is a
More informationHormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions
Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions IMPORTANCE OF HORMONE BALANCE Importance of Hormone Balance Help you live a long, healthy life Help you
More informationAging Well - Part V. Hormone Modulation -- Growth Hormone and Testosterone
Aging Well - Part V Hormone Modulation -- Growth Hormone and Testosterone By: James L. Holly, MD (The Your Life Your Health article published in the December 4th Examiner was a first draft. It was sent
More informationCoronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
More informationHow To Treat Dyslipidemia
An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia Introduction Executive Summary The International Atherosclerosis Society (IAS) here updates
More informationBarriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
More informationVictims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years
Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957
More informationThe Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
More informationGetting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research?
Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Jody Dushay, MD MMSc Beth Israel Deaconess Medical Center Boston, MA Session 445 No disclosures Disclosure Jody Dushay,
More informationWhat is a Heart Attack? 1,2,3
S What is a Heart Attack? 1,2,3 Heart attacks, otherwise known as myocardial infarctions, are caused when the blood supply to a section of the heart is suddenly disrupted. Without the oxygen supplied by
More informationHigh Blood Cholesterol
National Cholesterol Education Program ATP III Guidelines At-A-Glance Quick Desk Reference 1 Step 1 2 Step 2 3 Step 3 Determine lipoprotein levels obtain complete lipoprotein profile after 9- to 12-hour
More informationImproving cardiometabolic health in Major Mental Illness
Improving cardiometabolic health in Major Mental Illness Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Metabolic
More informationCan Common Blood Pressure Medications Cause Diabetes?
Can Common Blood Pressure Medications Cause Diabetes? By Nieske Zabriskie, ND High blood pressure, or hypertension, is a major risk factor for cardiovascular disease. In the United States, approximately
More informationBody Fat Distribution and Risk of Non-lnsulin-dependent Diabetes Mellitus in Women
American Journal of Epidemiology Copyright O 1997 by The Johns Hopkins University School of Hygiene and Public Hearth All rights reserved Vol 145, No. 7 Printed In U SA. Body Fat Distribution and Risk
More informationAssessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study
European Journal of Clinical Investigation (2007) 37, 925 932 DOI: 10.1111/j.1365-2362.2007.01888.x Blackwell Publishing Ltd Review Assessing risk of myocardial infarction and stroke: new data from the
More informationMain Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
More informationListen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
More informationTestosterone for women, who when and how much?
Medicine, Nursing and Health Sciences Testosterone for women, who when and how much? Susan R Davis MBBS FRACP PhD Women s Health Research Program School of Public Health Monash University Melbourne Medicine,
More informationTHE JEWISH HOSPITAL RESEARCH COUNCIL. 1. TITLE: Exogenous Testosterone and Venous Thrombosis in Patients with Underlying Clotting Abnormalities
THE JEWISH HOSPITAL RESEARCH COUNCIL 1. TITLE: Exogenous Testosterone and Venous Thrombosis in Patients with Underlying Clotting Abnormalities 2. DATE OF STUDY SUBMISSION: 1/3/14, Modification of Approved
More informationECONOMIC COSTS OF PHYSICAL INACTIVITY
ECONOMIC COSTS OF PHYSICAL INACTIVITY This fact sheet highlights the prevalence and health-consequences of physical inactivity and summarises some of the key facts and figures on the economic costs of
More informationWHAT DOES DYSMETABOLIC SYNDROME MEAN?
! WHAT DOES DYSMETABOLIC SYNDROME MEAN? Dysmetabolic syndrome (also referred to as syndrome X, insulin resistance syndrome, and metabolic syndrome ) is a condition in which a group of risk factors for
More informationCardiovascular Disease Risk Factors
Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or
More informationTestosterone: Is Just for the GOP?
Testosterone: Is Just for the GOP? Brad Anawalt, MD Vice Chair and Professor of Medicine University of Washington May 1, 2015 banawalt@medicine.washington.edu Testosterone continuum Severe hypogonadism
More information4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH
METABOLIC SYNDROME AN INTEGRATIVE APPROACH AN OPPORTUNITY FOR PHARMACISTS TO MAKE A DIFFERENCE Mike Rizo, Pharm D, MBA, ABAAHP THE EVOLUTION OF THE PHARMACIST 1920s 1960s 2000s THE PHARMACIST OF THE FUTURE?
More information3.5% 3.0% 3.0% 2.4% Prevalence 2.0% 1.5% 1.0% 0.5% 0.0%
S What is Heart Failure? 1,2,3 Heart failure, sometimes called congestive heart failure, develops over many years and results when the heart muscle struggles to supply the required oxygen-rich blood to
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationGuidelines for the management of hypertension in patients with diabetes mellitus
Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes
More informationINSULIN RESISTANCE AND COMPENSATORY HYPERINSULINEMIA: THE LINCHPIN BETWEEN OBESITY AND CARDIOVASCULAR DISEASE
May 2008 (Vol. 1, Issue 2, pages 4-10) INSULIN RESISTANCE AND COMPENSATORY HYPERINSULINEMIA: THE LINCHPIN BETWEEN OBESITY AND CARDIOVASCULAR DISEASE By Gerald M. Reaven, MD, Division of Cardiovascular
More informationA list of FDA-approved testosterone products can be found by searching for testosterone at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.
FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke
More informationAndrogens and CVD. Brandon Orr- Walker April 2014
Androgens and CVD Brandon Orr- Walker April 2014 Agenda What is normal physiology of Aging? Hypogonadism and disease If some is good is more becer? CVD safety Clinical features of Androgen Deficiency
More informationCardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better
Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.
More informationAppendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
More informationHDL Cholesterol Subfractions and the Effect of Testosterone Replacement in Hypogonadism
HDL Cholesterol Subfractions and the Effect of Testosterone Replacement in Hypogonadism E. Bolu 1, A. Sonmez 1, S. Tapan 2, A. Taslipinar 1, A. Aydogdu 1, C. Meric 1, Y. Basaran 1, G. Uckaya 1, M. Serdar
More informationAge Management Panel Male Fasting Panel
801 SW 16th St Suite 126 Renton WA 98057 Phone: 425.271.8689 Fax: 425.271.8689 CLIA # 50D0630590 Age Management Panel Male Fasting Panel Doctor ID 1001 Age 55 Date Collected 01/01/07 Patient Name DOE,
More informationCohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationThe Canadian Association of Cardiac
Reinventing Cardiac Rehabilitation Outside of acute care institutions, cardiovascular disease is a chronic, inflammatory process; the reduction or elimination of recurrent acute coronary syndromes is a
More informationTherapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
More informationNeal Rouzier responds to the JAMA article on Men and Testosterone
Neal Rouzier responds to the JAMA article on Men and Testosterone On the first day the JAMA article was released I received 500 emails from physicians and patients requesting my opinion of the article
More informationThe National Cholesterol Education Program s Adult
NHLBI/AHA Conference Proceedings Definition of Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
More informationShira Miller, M.D. Los Angeles, CA 310-734-8864 www.shiramillermd.com. The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library
Shira Miller, M.D. Los Angeles, CA 310-734-8864 The Compounding Pharmacy of Beverly Hills Beverly Hills Public Library 2 Outline What is hormone therapy? Why would healthy men and women need to think about
More informationTestosterone Replacement Therapy. Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division
Testosterone Replacement Therapy Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division Lecture Outline 1. Anatomy and physiology 2. Definition and etiology 3. Signs and symptoms
More informationPrevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus
Prevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus Hypogonadism is defined as deficient or absent male gonadal function
More informationHormone Replacement Therapy : The New Debate. Susan T. Hingle, M.D.
Hormone Replacement Therapy : The New Debate Susan T. Hingle, M.D. Background Hormone replacement therapy (HRT) is extensively used in the United States, especially for: *treatment of menopausal symptoms
More informationMENOPAUSE WOMAN'S TEST (Assessment of hormone balance)
ATTACHMENT: Useful remarks for patient and doctor, to be associated to the analytical results. Your doctor should interpret this report. Cod. ID: 123456 CCV: 6bf Date: 01/01/2013 Patient: Rossi Mario Rapport
More informationPractical Applications of Insulin Pump Therapy in Type 2 Diabetes
Practical Applications of Insulin Pump Therapy in Type 2 Diabetes Wendy Lane, MD For a CME/CEU version of this article please go to www.namcp.org/cmeonline.htm, and then click the activity title. Summary
More informationUs TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy
Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Today s speaker is Samir Taneja, MD Program moderator is Pam Barrett, Us TOO International Made possible
More informationincidence of coronary heart disease and occur in persons aged 65 and older; yet disease for middle-aged white males; little
HEARTBEAT Cardiovascular Health Study Spring 1993 Special Issue To our CHS participants: Many of you are now in your fourth year as participants in the Cardiovascular Health Study. The time and energy
More informationT he relation between alcohol intake and risk of type II
542 RESEARCH REPORT Alcohol consumption and the incidence of type II diabetes S G Wannamethee, A G Shaper, I J Perry, KGMMAlberti... J Epidemiol Community Health 2002;56:542 548 See end of article for
More informationIs the Apparent Cardioprotective Effect of Recent Alcohol Consumption Due to Confounding by Prodromal Symptoms?
American Journal of Epidemiology Copyright 2000 by The Johns Hopkfns University School of Hygiene and Public Health Allrightsreserved Vol. 151, No. 12 Printed In USA. Is the Apparent Cardioprotective Effect
More informationROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE
ROLE OF LDL CHOLESTEROL, HDL CHOLESTEROL AND TRIGLYCERIDES IN THE PREVENTION OF CORONARY HEART DISEASE AND STROKE I- BACKGROUND: Coronary artery disease and stoke are the major killers in the United States.
More informationOriginal Article INTRODUCTION. Wan Chul Lee 1, Ma Tae Kim 1, Kyung Tae Ko 1, Won Ki Lee 2, Sung Yong Kim 1, Ha Young Kim 1, Dae Yul Yang 1
pissn: 2287-4208 / eissn: 2287-4690 World J Mens Health 2014 December 32(3): 139-144 http://dx.doi.org/10.5534/wjmh.2014.32.3.139 Original Article Relationship between Serum Testosterone and Cardiovascular
More informationHow To Know If You Have Microalbuminuria
3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate
More informationGuidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
More informationDiabetes and Stroke. Understanding the connection between diabetes and the increased risk of stroke
Diabetes and Stroke Understanding the connection between diabetes and the increased risk of stroke Make the Connection Almost 26 million people in the U.S. roughly 8 percent of the population have diabetes.
More informationHow To Diagnose Late Onset Hypogonadism
The clinical picture of male hypogonadism Professor Myles Spar Classic signs and symptoms Definitions Late onset hypogonadism (LOH, also referred to as age-associated testosterone deficiency [TDS]) is
More informationInsulin Resistance and PCOS: A not uncommon reproductive disorder
Insulin Resistance and PCOS: A not uncommon reproductive disorder Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA Diplomate Accrediation Council for Clinical Lipidology President Preventive Cardiovascular Nurses
More informationTreatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
Complete Summary GUIDELINE TITLE (1)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment
More informationCORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE
CORPORATE HEALTH LOWERING YOUR CHOLESTEROL & BLOOD PRESSURE What is Cholesterol? What s wrong with having high cholesterol? Major risk factor for cardiovascular disease Higher the cholesterol higher the
More informationDietary Composition for Weight Loss and Weight Loss Maintenance
Dietary Composition for Weight Loss and Weight Loss Maintenance Bridget M. Hron, MD Instructor in Pediatrics, Harvard Medical School Staff Physician in Gastroenterology & Nutrition and New Balance Foundation
More informationEvaluation of Androgen Levels in Patients with Acute Coronary Syndrome
Evaluation of Androgen Levels in Patients with Acute Coronary Syndrome Fatma Dilek Dellal 1, Mutlu Niyazoğlu 2, Tamer Çeviker 3, Süheyla Görar 4, Ertuğrul Taşan 5 1 Endocrinology, Agri Government Hospital,
More informationMale Health. The three major issues are: Cardiovascular Health Prostate Health Fertility & Sexual Performance
Male Health Do Men Value Their Health? The ancient Greek physician Hippocrates once said, A wise man ought to realise that his health is his most valuable possession. It is believed that Hippocrates lived
More informationProtocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials. Version: 1. Date: 5 th December 2011
Protocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials Version: 1 Date: 5 th December 2011 Study team: C Mary Schooling, CUNY School of Public Health
More informationFrom Menses to Menopause: How Hormones Can Affect Blood Glucose Levels. Christine Day, RN, MS, CNS-BC Lake Superior College
From Menses to Menopause: How Hormones Can Affect Blood Glucose Levels Christine Day, RN, MS, CNS-BC Lake Superior College Overview Will review hormonal changes over the female lifespan Discuss the effects
More information